CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY MARKET BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Rising occurrences of aortic aneurysm
3.6.1.2. Growing geriatric population worldwide
3.6.1.3. Technological advancements in EVAR procedures and devices
3.6.1.4. Availability of favorable reimbursement for EVAR procedures and devices
3.6.2. Restraints
3.6.2.1. High cost associated with treatment procedures
3.6.2.2. Lack of awareness in developing region
3.6.3. Opportunities
3.6.3.1. Improvement in EVAR technologies and devices
CHAPTER 4 ENDOVASCULAR ANEURYSM REPAIR (EVAR), BY INDICATION
4.1. OVERVIEWGLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET: INDICATION
4.1.1. Market size and forecast
4.2. ABDOMINAL AORTIC ANEURYSM (AAA)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. THORACIC AORTIC ANEURYSM (TAA)
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Ascending thoracic aortic aneurysm
4.3.4.1. Market size and forecast
4.3.5. Descending thoracic aortic aneurysm
4.3.5.1. Market size and forecast
4.3.6. Thoracic arch aneurysm
4.3.6.1. Market size and forecast
4.3.7. Thoracoabdominal aortic aneurysm (TAAA)
4.3.7.1. Market size and forecast
CHAPTER 5 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. INFRARENAL SITE
5.2.1. Market size and forecast
5.3. PARARENAL
5.3.1. Market size and forecast
5.3.2. Juxtarenal
5.3.2.1. Market size and forecast
5.3.3. Suprarenal
5.3.3.1. Market size and forecast
CHAPTER 6 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. TRADITIONAL
6.2.1. Market size and forecast
6.3. COMPLEX
6.3.1. Market size and forecast
CHAPTER 7 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. PERCUTANEOUS EVAR
7.2.1. Market size and forecast
7.3. FENESTRATED EVAR
7.3.1. Market size and forecast
7.4. AORTIC STENT & TAA GRAFT
7.4.1. Market size and forecast
7.5. OTHERS
7.5.1. Market size and forecast
CHAPTER 8 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. India market size and forecast
8.4.3.2. Japan market size and forecast
8.4.3.3. China market size and forecast
8.4.3.4. Australia market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Thailand market size and forecast
8.4.3.7. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. South Africa market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Turkey market size and forecast
8.5.3.5. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. MEDTRONIC PLC
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments
9.2. COOK MEDICAL INC.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. ENDOLOGIX INC.
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. W. L. GORE & ASSOCIATES, INC.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. CARDINAL HEALTH INC.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. C. R. BARD, INC.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments
9.7. MERCK & CO., INC.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. LOMBARD MEDICAL, INC.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. TERUMO CORPORATION
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. ABBOTT LABORATORIES
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments